Literature DB >> 30439470

The first reported case of pelvic inflammatory disease caused by Actinobaculum massiliense.

José Antonio Carrillo-Ávila1, Laura Bonilla-García2, José María Navarro-Marí3, José Gutiérrez-Fernández4.   

Abstract

We report the first case of pelvic inflammatory disease (PID) caused by Actinobaculum massiliense. A 53-year-old woman attended the emergency department with symptoms compatible with a PID episode, finally resolved by intramuscular antibiotic treatment. Actinobaculum sp. was isolated by culture, and A. massiliense was confirmed by matrix assisted laser desorption time-of-flight mass spectrometry and 16S rRNA gene sequencing. Only a few cases of A. massiliense infections have been reported, and the pathogenesis of infections by these bacteria is poorly understood. The introduction of new diagnostic methods into hospital routines will improve the detection of new and little-studied pathogens.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actinobaculum massiliense; Emerging infection; Genital infection

Mesh:

Substances:

Year:  2018        PMID: 30439470     DOI: 10.1016/j.anaerobe.2018.11.006

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  3 in total

1.  Emerging Presence of Culturable Microorganisms in Clinical Samples of the Genitourinary System: Systematic Review and Experience in Specialized Care of a Regional Hospital.

Authors:  Antonio Rosales-Castillo; Gemma Jiménez-Guerra; Lara Ruiz-Gómez; Manuela Expósito-Ruíz; José María Navarro-Marí; José Gutiérrez-Fernández
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

Review 2.  [Pelvic inflammatory disease by Streptococcus constellatus. Clinical experience and a review].

Authors:  J C Mora-Palma; V Guillot-Suay; M M Sánchez Gila; J Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2020-06-09       Impact factor: 1.553

3.  [Recent prevalence among females from the general population of agents responsible for sexually transmitted infections and other genital infections].

Authors:  María Ruiz-Olivares; Carla Foronda-García-Hidalgo; Sara Sanbonmatsu-Gámez; José Gutiérrez-Fernández
Journal:  Aten Primaria       Date:  2020-03-05       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.